Circulating TB levels were weakly associated with liver fat fraction in patients with NAFLD, and the circulating UGT1A1 levels were positively correlated with liver fat fraction in NAFLD patients with severe steatosis. This evidence concerns the gene UGT1A1 and metabolic dysfunction-associated steatotic liver disease.